首页> 外文OA文献 >Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial

【2h】

Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial

机译：在转移性甲状腺髓样癌中使用抗癌胚抗原双特异性抗体和68Ga标记肽进行免疫PET：在人类首次试验中预靶向参数的临床优化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Bodet-Milin, Caroline,; Faivre-Chauvet, Alain,; Carlier, Thomas,; Rauscher, Aurore,; Bourgeois, Mickael,; Cerato, Evelyne,; Rohmer, Vincent; Couturier, Olivier,; Drui, Delphine; Goldenberg, David,; Sharkey, Robert,; Barbet, Jacques,; Kraeber-Bodere, Francoise,;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial [J] . Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, The Journal of Nuclear Medicine . 2016,第10期

机译：在转移性甲状腺髓样癌中使用抗癌胚抗原双特异性抗体和68Ga标记肽进行免疫PET：在首次人类试验中预靶向参数的临床优化
2. Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and Ga-68-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial [J] . Bodet-Milin Caroline, Faivre-Chauvet Alain, Carlier Thomas, The Journal of Nuclear Medicine . 2016,第10期

机译：在转移性甲状腺髓样癌中使用抗癌胚抗原双特异性抗体和Ga-68标签肽的Immuno-PET：在人类首次试验中预靶向参数的临床优化
3. Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: Biomarker response and survival improvement [J] . SalaunP.-Y., CampionL., BournaudC., The Journal of Nuclear Medicine . 2012,第8期

机译：抗癌胚抗原预靶向放射免疫疗法在进行性转移性甲状腺髓样癌中的II期试验：生物标志物反应和生存改善
4. Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches [O] . Caroline Bodet-Milin, Clément Bailly, Yann Touchefeu, 2019

机译：甲状腺髓样癌的临床结果表明针对肿瘤成像和治疗方法的预靶向免疫PET的潜力很大
5. Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial [O] . Bodet-Milin, Caroline,, Faivre-Chauvet, Alain,, Carlier, Thomas,, 2016

机译：在转移性甲状腺髓样癌中使用抗癌胚抗原双特异性抗体和68Ga标记肽进行免疫PET：在首次人类试验中对预靶向参数的临床优化

Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial

摘要

著录项

相似文献

相关主题

期刊订阅